High glucose enhanced lipoprotein(a) [Lp(a)] oxidation in a manner inhibited by eicosapentaenoic acid (EPA) in vitro

Back

ESC Professional Premium Access

High glucose enhanced lipoprotein(a) [Lp(a)] oxidation in a manner inhibited by eicosapentaenoic acid (EPA) in vitro

Session: Lipids: new pathophysiological and therapeutic insights

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Speaker: Doctor P. Mason (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Preston Mason

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

2 presentations

0 follower

6 more presentations in this session

Rare genetic variants in LDLR, APOB, and PCSK9 are associated with aortic stenosis

Speaker: Mr S. Jurgens (Cambridge, US)

Lipidomics-based deep learning algorithms can enhance prediction of obstructive coronary artery disease

Speaker: Doctor E. Karagiannidis (Thessaloniki, GR)

Peroxisome proliferator-activated receptor gamma regulates interleukin-6 induced lipoprotein(a) gene expression in human HepG2 cells

Speaker: Doctor T. Harb (Baltimore, US)

Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associated steatohepatitis in mice

Speaker: Doctor S. Pagano (Geneva, CH)

Beyond LDL-cholesterol: effects of alirocumab on the human apolipoproteome

Speaker: Mr L. Schmidt (Vienna, AT)

Access the full session

Lipids: new pathophysiological and therapeutic insights

Speakers: Doctor P. Mason, Mr S. Jurgens, Doctor E. Karagiannidis, Doctor T. Harb, Doctor S. Pagano...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources